| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.34 | 0.05 |